Advertisement
Demo

Novartis trial shows no benefits from Pear's schizophrenia app as CEO cites trial irregularities

Jan 14, 2021 jonah.comstock@mobihealthnews.com (Jonah Comstock), Mobile Health News
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.

Read the full story...


Trending healthcare news keywords at this moment

covid- vaccine pandemic cancer covid vaccines study